BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Astrazeneca Pharma India Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
506820
ISIN Demat
INE203A01020
Book Value (Rs)
319.6
NSE Symbol
ASTRAZEN
Divident Yield %
0.38
Market Cap
(Rs In Cr.)
21,023
P/E (TTM)
90.94
EPS (TTM)
92.47
Face Value
(Rs)
2
Back
Astrazeneca Pharma India standalone net profit rises 41.09% in the September 2025 quarter
08-Nov-25   Hrs IST

Net profit of Astrazeneca Pharma India rose 41.09% to Rs 54.22 crore in the quarter ended September 2025 as against Rs 38.43 crore during the previous quarter ended September 2024. Sales rose 37.03% to Rs 559.09 crore in the quarter ended September 2025 as against Rs 408.00 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales559.09408.00 37
OPM %13.4512.88 -
PBDT80.6860.35 34
PBT78.1151.03 53
NP54.2238.43 41

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)